Abstract
Mentally and physically handicapped patients with epilepsy may have an increased risk of osteoporosis due to different reasons: alimentary problems, lack of sport, chronic medication, especially antiepileptic drugs. Patients with special syndromes have an elevated risk for osteoporosis, especially people with Down syndrome. Other reasons may play a role: comorbidity, lack of sunlight exposure, lack of information about osteoporosis.
Zusammenfassung
Mehrfachbehinderte Menschen mit Epilepsie haben möglicherweise ein erhöhtes Osteoporoserisiko aufgrund von Ernährungsmängel mit Unter– oder Übergewicht, Bewegungsmangel, chronischer Medikation, insbesondere Antiepileptika. Patienten mit speziellen Syndromen, insbesondere Down–Syndrom haben ein höheres Risiko bei der Entwicklung einer Osteoporose. Weiterhin sind Begleiterkrankungen, geringe Sonnenlichtexposition und mangelnde Informiertheit (von Patienten und Betreuer) möglicherweise wichtige Gründe für die erhöhte Inzidenz von Osteoporose in dieser Patientengruppe.
Similar content being viewed by others
References
Allgemeine Empfehlungen der deutschen Gesellschaft für Osteologie zur Prophylaxe der Osteoporose: http://www. uni–duesseldorf.de/ WWW/AWMF/ll/034–002. htm
Berry JL, Mawer EB, Walker DA (1983) Effect of antiepileptic drug therapy and exposure to sunlight on Vitamin D status in institutionalized patients. In: Oxley J, Janz D, Meinardi H (eds) Antiepileptic therapy: chronic toxicity of antiepileptic drugs. Raven Press, New York, pp 185–192
Boluk A, Guzelipek M, Savli H, Temel I, Ozisik HI, Kaygusuz A (2004) The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 50:93–97
Churesigaew S, Ruvalcaba RH, Kelley VC (1975) Epilepsy and abnormal calcium metabolism in institutionalized mentally retarded patients. Am J Ment Defic 79:738–741
Desai KB, Ribbans WJ, Taylor GJ (1996) Incidence of five common fracture types in an institutional epileptic population. Injury 27:97–100
DNA direkt. http://www. dna–direkt.de/botframe_files/osteoporose.htm
Drezner MK (2004) Treatment of anticonvulsant drug–induced bone disease. Epilepsy Behav 5(Suppl 2):S41– 47
Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El–Hajj Fuleihan G (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology (14)58:1348–1353
Fitzpatrick LA (2004) Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav (Suppl 2):S3–15
Leitlinien des Qualitätszirkel norddeutschen AG ärztliche Dienste für Menschen mit geistiger Behinderung (2000)
Lidgren L, Walloe A (1997) Incidence of fractures in epileptics. Acta Orthop Scand 48:356–361
Lloyd ME, Spector TD, Howard R (2000) Osteoporosis in neurological disorders. J Neurol Neurosurg Psychiatry 68:543–547
Lohiya GS, Crinella FM, Tan–Figueroa L, Caires S, Lohiya S (1999) Fracture epidemiology and control in a developmental center. West J Med 170(4):203– 209
Lohiya GS, Tan–Figueroa L, Iannucci A (2004) J Identification of low bone mass in a developmental center: finger bone mineral density measurement in 562 residents. Am Med Dir Assoc 5(6):371–376
Lohiya GS, Lohiya S, Tan–Figueroa L (1999) Eighteen fractures in a man with profound mental retardation. Ment Retard 37(1):47–51
Mattson RH, Gidal BE (2004) Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 5(Suppl 2):S36–40
Mugica I, Ansa J, Sistiaga F, Zabalza R, Zubillaga P, Merino A, Mojedano B, Vidal C (2002) Digital computerized absorptiometry in the diagnosis of osteoporosis in a group of the severely mentally retarded. Nutr Hosp 17(4):213–218
Pack AM, Morrell MJ (2004) Epilepsy and bone health in adults. Epilepsy Behav 5(Suppl 2):S24–29
Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 14;57(3):445–449
Shath RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB (1995) Effect of carbamazepine and valproate on bone mineral density. J Pediatr 127(2):256– 262
Sheth RD (2002) Bone health in epilepsy. Epilepsia 43(12):1453–1454
Stephen LJ, McLellan AR, Harrsion JH, Shapiro D, Dominiczak MH, Sills GJ, Brodie MJ (1999) Bone density and antiepileptic drugs: a case–controlled study. Seizure 8(6):339–342
Thorbecke R (2003) Sport bei Epilepsie. In: Wolf P (ed) (Hrsg) Praxisbuch Epilepsie, Kohlhammer Verlag, S 313– 318
Van Allen MI, Fung J, Jurenka SB (1999) Health care concerns and guidelines for adults with Down syndrome. Am J Med Genet 25;89(2):100–110
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mayer, T. Besondere Bedeutung von Knochenstoffwechselstörungen bei mehrfach–behinderten Menschen mit Epilepsie. Z. Epileptol. 18, 178–183 (2005). https://doi.org/10.1007/s10309-005-0144-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10309-005-0144-2